688105.SH
诺唯赞
SSE · Healthcare · Biotechnology · CN
CNY 22.51
−7.14%Margins
Gross margin
69.9%
EBITDA margin
8.6%
EBIT margin
-3.0%
Net margin
-1.0%
FCF margin
11.9%
-0.4%
Return on equity
-0.3%
Return on assets
-0.9%
Return on invested capital
0.28x
Asset turnover
CNY 209.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026